ENTRY       D00292                      Drug
NAME        Dexamethasone (JP18/USP/INN);
            Decadron (TN);
            Maxidex (TN)
PRODUCT     DEXTENZA (Ocular Therapeutix)
            DEXYCU (EyePoint Pharmaceuticals US)
            HEMADY (Acrotech Biopharma LLC)
            MAXIDEX (Novartis Pharmaceuticals Corporation)
            OZURDEX (Allergan)
  GENERIC   DEXAMETHASONE (A-S Medication Solutions)
            DEXAMETHASONE (A-S Medication Solutions)
            DEXAMETHASONE (A-S Medication Solutions)
            DEXAMETHASONE (A-S Medication Solutions)
            DEXAMETHASONE (ANI Pharmaceuticals)
            DEXAMETHASONE (Advanced Rx Pharmacy of Tennessee)
            DEXAMETHASONE (Advanced Rx Pharmacy of Tennessee)
            DEXAMETHASONE (Alvogen)
            DEXAMETHASONE (American Health Packaging)
            DEXAMETHASONE (Amneal Pharmaceuticals NY LLC)
            DEXAMETHASONE (Amneal Pharmaceuticals NY LLC)
            DEXAMETHASONE (AvKARE)
            DEXAMETHASONE (Bionpharma Inc.,)
            DEXAMETHASONE (Bionpharma Inc.,)
            DEXAMETHASONE (Bryant Ranch Prepack)
            DEXAMETHASONE (Bryant Ranch Prepack)
            DEXAMETHASONE (Bryant Ranch Prepack)
            DEXAMETHASONE (Bryant Ranch Prepack)
            DEXAMETHASONE (Cardinal Health 107)
            DEXAMETHASONE (Cardinal Health 107)
            DEXAMETHASONE (Chartwell RX)
            DEXAMETHASONE (Direct Rx)
            DEXAMETHASONE (Direct Rx)
            DEXAMETHASONE (Direct_Rx)
            DEXAMETHASONE (Direct_Rx)
            DEXAMETHASONE (Direct_Rx)
            DEXAMETHASONE (Doc Rx)
            DEXAMETHASONE (Fera Pharmaceuticals)
            DEXAMETHASONE (Golden State Medical Supply)
            DEXAMETHASONE (Key Therapeutics)
            DEXAMETHASONE (Larken Laboratories)
            DEXAMETHASONE (Larken Laboratories)
            DEXAMETHASONE (Major Pharmaceuticals)
            DEXAMETHASONE (NorthStar Rx LLC)
            DEXAMETHASONE (NuCare Pharmaceuticals)
            DEXAMETHASONE (NuCare Pharmaceuticals)
            DEXAMETHASONE (PD-Rx Pharmaceuticals)
            DEXAMETHASONE (PD-Rx Pharmaceuticals)
            DEXAMETHASONE (PD-Rx Pharmaceuticals)
            DEXAMETHASONE (Pharmaceutical Associates)
            DEXAMETHASONE (Prasco Laboratories)
            DEXAMETHASONE (Preferred Pharmaceuticals)
            DEXAMETHASONE (Preferred Pharmaceuticals)
            DEXAMETHASONE (Preferred Pharmaceuticals)
            DEXAMETHASONE (Preferred Pharmaceuticals)
            DEXAMETHASONE (Preferred Pharmaceuticals)
            DEXAMETHASONE (Proficient Rx LP)
            DEXAMETHASONE (Proficient Rx LP)
            DEXAMETHASONE (Proficient Rx LP)
            DEXAMETHASONE (Quality Care Products)
            DEXAMETHASONE (REMEDYREPACK)
            DEXAMETHASONE (REMEDYREPACK)
            DEXAMETHASONE (REMEDYREPACK)
            DEXAMETHASONE (RedPharm Drug)
            DEXAMETHASONE (RedPharm Drug)
            DEXAMETHASONE (Redpharm Drug)
            DEXAMETHASONE (Rising Pharma Holdings)
            DEXAMETHASONE (STI Pharma LLC)
            DEXAMETHASONE (medsource pharmaceuticals)
            DEXAMETHASONE 6-DAY (Xspire Pharma)
            DEXAMETHASONE INTENSOL (Hikma Pharmaceuticals USA)
            TAPERDEX 12-DAY (Proficient Rx LP)
            TAPERDEX 12-DAY (Xspire Pharma)
            TAPERDEX 6-DAY (Proficient Rx LP)
            TAPERDEX 6-DAY (Xspire Pharma)
            TAPERDEX 7-DAY (Xspire Pharma)
FORMULA     C22H29FO5
EXACT_MASS  392.1999
MOL_WEIGHT  392.4611
CLASS       Anti-inflammatory
             DG01955  Corticosteroid
              DG02068  Glucocorticoid
            Dermatological agent
             DG03243  Atopic dermatitis agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inducer
             DG02853  CYP3A/CYP3A4 inducer
              DG01635  CYP3A4 inducer
REMARK      Same as: C15643
            Therapeutic category: 1315 2399 2454 2646
            ATC code: A01AC02 C05AA09 D07AB19 D07XB05 D10AA03 H02AB02 R01AD03 S01BA01 S01CB01 S02BA06 S03BA01
            Chemical structure group: DG00011
            Product (DG00011): D00292<JP/US> D00975<JP/US> D01510<JP> D01615<JP> D01632<JP> D01948<JP> D07073<JP>
            Product (mixture): D08733<JP> D10296<US> D11177<US> D11178<US>
EFFICACY    Anti-inflammatory, Antipruritic, Glucocorticoid receptor agonist
  DISEASE   Diabetic macular edema [DS:H01651]
            Asthma [DS:H00079]
            Atopic dermatitis [DS:H01358]
            Contact dermatitis [DS:H01357]
            Allergic rhinitis [DS:H01360]
            Bullous dermatitis herpetiformis [DS:H01362]
            Mycosis fungoides [DS:H01463]
            Pemphigus [DS:H01648]
            Erythema multiforme [DS:H01695]
            Stevens-Johnson syndrome [DS:H01694]
            Congenital adrenal hyperplasia [DS:H00216]
            Ulcerative colitis [DS:H01466]
            Acquired (autoimmune) hemolytic anemia [DS:H01585]
            Congenital (erythroid) hypoplastic anemia; Diamond-Blackfan anemia [DS:H00237]
            Pure red cell aplasia [DS:H01586]
            Multiple sclerosis [DS:H01490]
            Temporal arteritis [DS:H01698]
            Nephrotic syndrome [DS:H01657]
            Pulmonary tuberculosis [DS:H00342]
            Acute gouty arthritis [DS:H01532]
            Ankylosing spondylitis [DS:H01674]
            Psoriatic arthritis [DS:H01507]
            Rheumatoid arthritis [DS:H00630]
            Juvenile rheumatoid arthritis [DS:H01672]
            Dermatomyositis and polymyositis [DS:H01604]
            Systemic lupus erythematosus [DS:H00080]
TARGET      NR3C1 (GR) [HSA:2908] [KO:K05771]
  PATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION CYP induction: CYP3A4 [HSA:1576]
STR_MAP     map07043  Antineoplastics - hormones
            map07046  Immunosuppressive agents
            map07225  Glucocorticoid and mineralocorticoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A01 STOMATOLOGICAL PREPARATIONS
               A01A STOMATOLOGICAL PREPARATIONS
                A01AC Corticosteroids for local oral treatment
                 A01AC02 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
             C CARDIOVASCULAR SYSTEM
              C05 VASOPROTECTIVES
               C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
                C05AA Corticosteroids
                 C05AA09 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
             D DERMATOLOGICALS
              D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
               D07A CORTICOSTEROIDS, PLAIN
                D07AB Corticosteroids, moderately potent (group II)
                 D07AB19 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
               D07X CORTICOSTEROIDS, OTHER COMBINATIONS
                D07XB Corticosteroids, moderately potent, other combinations
                 D07XB05 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
              D10 ANTI-ACNE PREPARATIONS
               D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
                D10AA Corticosteroids, combinations for treatment of acne
                 D10AA03 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H02 CORTICOSTEROIDS FOR SYSTEMIC USE
               H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
                H02AB Glucocorticoids
                 H02AB02 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
             R RESPIRATORY SYSTEM
              R01 NASAL PREPARATIONS
               R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
                R01AD Corticosteroids
                 R01AD03 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01B ANTIINFLAMMATORY AGENTS
                S01BA Corticosteroids, plain
                 S01BA01 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
               S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
                S01CB Corticosteroids/antiinfectives/mydriatics in combination
                 S01CB01 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
              S02 OTOLOGICALS
               S02B CORTICOSTEROIDS
                S02BA Corticosteroids
                 S02BA06 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
              S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
               S03B CORTICOSTEROIDS
                S03BA Corticosteroids
                 S03BA01 Dexamethasone
                  D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
              Dexamethasone
               D00292  Dexamethasone (JP18/USP/INN)
             Inflammatory Bowel Disease Agents
              Glucocorticoids
               Dexamethasone
                D00292  Dexamethasone (JP18/USP/INN)
             Ophthalmic Agents
              Ophthalmic Anti-inflammatories
               Glucocorticoids, Ophthalmic
                Dexamethasone
                 D00292  Dexamethasone (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1315  Ophthalmic cortisones
                 D00292  Dexamethasone (JP18/USP/INN)
             2  Agents affecting individual organs
              23  Digestive organ agents
               239  Miscellaneous
                2399  Others
                 D00292  Dexamethasone (JP18/USP/INN)
              24  Hormones
               245  Adrenal hormone preparations
                2454  Fluorinated adrenocorticotropic hormones
                 D00292  Dexamethasone (JP18/USP/INN)
              26  Epidermides
               264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
                2646  Adrenocorticotropic hormones
                 D00292  Dexamethasone (JP18/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
               D00292  Dexamethasone (JP18/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Designated second-class OTC drugs
              Inorganic and organic chemicals
               Dexamethasone
                D00292  Dexamethasone (JP18/USP/INN)
             Second-class OTC drugs
              Inorganic and organic chemicals
               Dexamethasone
                D00292  Dexamethasone (JP18/USP/INN)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00011  Dexamethasone
                 D00292  Dexamethasone
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00292  Dexamethasone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00011  Dexamethasone
                 D00292  Dexamethasone
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00011  Dexamethasone
                 D00292  Dexamethasone
            Drug classes [BR:br08332]
             Anti-inflammatory
              DG01955  Corticosteroid
               D00292  Dexamethasone
             Dermatological agent
              DG03243  Atopic dermatitis agent
               D00292  Dexamethasone
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                NR3C1 (GR)
                 D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00292  Dexamethasone
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00292
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00292
            Topical steroids potency [br08317.html]
             Classification in Japan
              D00292
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01955  Corticosteroid
               DG02068  Glucocorticoid
                DG00011  Dexamethasone
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00011  Dexamethasone
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00011  Dexamethasone
DBLINKS     CAS: 50-02-2
            PubChem: 7847358
            ChEBI: 41879
            PDB-CCD: DEX
            LigandBox: D00292
            NIKKAJI: J1.356K
ATOM        28
            1   C2x C     6.5292  -16.7310
            2   C5x C     6.5292  -18.0917
            3   C2x C     7.7075  -18.7720
            4   C2y C     8.8859  -18.0917
            5   C1z C     8.8859  -16.7310
            6   C2x C     7.7075  -16.0507
            7   C1x C    10.0643  -18.7720
            8   C1x C    11.2426  -18.0917
            9   C1y C    11.2426  -16.7310
            10  C1z C    10.0643  -16.0507
            11  C1y C    12.4210  -16.0507
            12  C1z C    12.4210  -14.6900
            13  C1x C    11.2426  -14.0097
            14  C1y C    10.0643  -14.6900
            15  C1x C    14.7777  -16.0507
            16  C1y C    14.7777  -14.6900
            17  C1z C    13.5994  -14.0097
            18  C1a C     8.8859  -15.3703
            19  O1a O     8.8879  -14.0109
            20  C1a C    12.4210  -13.3294
            21  C1a C    15.9436  -14.0168
            22  C5a C    13.5994  -12.3089
            23  X   F    10.0643  -17.4113
            24  O1a O    14.7777  -13.1194
            25  O5x O     5.3509  -18.7720
            26  O5a O    14.7817  -11.6263
            27  C1b C    12.4249  -11.6308
            28  O1a O    11.2650  -12.3007
BOND        31
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   10  14 1
            17   11  15 1
            18   15  16 1
            19   16  17 1
            20   12  17 1
            21    5  18 1 #Up
            22   14  19 1 #Up
            23   12  20 1 #Up
            24   16  21 1 #Down
            25   17  22 1 #Up
            26   10  23 1 #Down
            27   17  24 1 #Down
            28    2  25 2
            29   22  26 2
            30   22  27 1
            31   27  28 1
///
